Ribocure Pharmaceuticals AB
3 clinical trials · Sponsor
◉ Watch Ribocure Pharmaceuticals AB
| Record | Firm | Date |
|---|---|---|
| Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia (NCT06797401) | Ribocure Pharmaceuticals AB | 2025-01-28 |
| A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of RBD4059 in Participants With Stable Coronary Artery Disease (NCT06717074) | Ribocure Pharmaceuticals AB | 2024-08-28 |
| Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of RBD1016 in Participants With Chronic Hepatitis D (NCT06649266) | Ribocure Pharmaceuticals AB | 2024-08-21 |
Track Ribocure Pharmaceuticals AB automatically
Every clearance here is in the API, with alerts when new ones post.